<DOC>
	<DOCNO>NCT02555709</DOCNO>
	<brief_summary>This two-part , randomize , double-blind , placebo-controlled study VTP-43742 administer normal healthy volunteer ( NHV ) moderate severe psoriatic patient , sequential ascend dose panel .</brief_summary>
	<brief_title>An Ascending Multiple Dose Study With VTP-43742 Healthy Volunteers Psoriatic Patients</brief_title>
	<detailed_description>This prospective , randomize , double-blind , placebo-controlled , ascend multiple dose study evaluate safety , tolerability , pharmacokinetics , pharmacodynamics effect VTP-43742 healthy volunteer conduct single , study center patient moderate severe chronic plaque-type psoriasis approximately 8 study center United States . A total 108 participant enrol study ( 48 healthy subject 60 psoriatic patient ) .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Healthy Volunteer Healthy male female , 18 45 year age , inclusive . Body weight least 55 kg body mass index 1832 kg/m2 , inclusive . Medically healthy clinically insignificant screen result . Women childbearing potential ( WOCBP ) may enrol agree use two reliable form contraception Men partner WOCBP must agree and/or partner use two reliable form contraception WOCBP must negative serum βhCG pregnancy test Checkin visit . Voluntarily consent participate trial Psoriasis Patient Confirmed diagnosis chronic plaquetype psoriasis , diagnose least 6 month study least moderate severity , define PASI≥10 , PGA≥3 , % BSA≥8 Otherwise medically healthy otherwise clinically insignificant screen laboratory test result Males female , 18 75 year age , inclusive Body weight least 55 kg body mass index 1835 kg/m2 , inclusive . WOCBP may enrol agree use two reliable form contraception Men partner WOCBP must agree and/or partner use two reliable form contraception WOCBP must negative serum β hCG pregnancy test Screening Baseline visit Voluntarily consent participate trial Healthy Volunteer Unwilling unable provide write informed consent History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , coagulation , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease Evidence organ dysfunction clinically significant deviation normal vital sign , physical examination , clinical laboratory determination ECG Any major surgery within 3 month Screening Positive urine drug/alcohol test Screening Baseline visit Use tobacco and/or nicotinecontaining product within 3 month prior start dose trial Positive test human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCV Ab ) Screening History presence alcoholism drug abuse define DSM V , Diagnostic Criteria Drug Alcohol Abuse History hypersensitivity idiosyncratic reaction drug multiple drug class Any previous gastrointestinal surgery recent ( within 3 month ) history gastrointestinal disease could impact absorption study drug Blood donation significant blood loss within 8 week prior Day 1of trial Plasma donation within 7 day prior Day 1 trial Blood transfusion within 4 week Screening Positive serum pregnancy test ( WOCBP ) Screening Baseline visit Prisoners subject compulsorily detain ( involuntarily incarcerate ) treatment either psychiatric physical disease ( e.g. , infectious disease ) must enrol study Any medical , psychiatric , /or social reason determine Investigator Psoriatic Patient Unwilling unable provide write informed consent Efficacy failure two biological agent treatment psoriasis failure occur within one year initiation therapy first biological agent Current treatment history treatment psoriasis biologicals within 6 month study Day 1 Current treatment history treatment psoriasis nonbiological systemic medication within 4 week Day 1 treatment topical agent within 2 week Day 1 History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , coagulation , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease Evidence organ dysfunction clinically significant deviation normal vital sign , physical examination , clinical laboratory determination ECG Any major surgery within 3 month Screening Positive test human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCV Ab ) Screening History presence alcoholism drug abuse define DSM IV , Diagnostic Criteria Drug Alcohol Abuse History hypersensitivity idiosyncratic reaction drug multiple drug class Any previous gastrointestinal surgery recent ( within 3 month ) history gastrointestinal disease could impact absorption study drug Blood donation significant blood loss within 8 week prior Day 1 trial Plasma donation within 7 day prior Day 1 trial Blood transfusion within 4 week Screening Positive serum pregnancy test ( WOCBP ) Screening positive urine pregnancy test confirmatory serum pregnancy test Day 1 Prisoners subject compulsorily detain ( involuntarily incarcerate ) treatment either psychiatric physical disease ( e.g. , infectious disease ) must enrol study . Any medical , psychiatric , /or social reason determine Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>